Company Filing History:
Years Active: 2018
Title: Masako Miyazaki: Innovator in Neurodegenerative Disease Treatment
Introduction
Masako Miyazaki is a prominent inventor based in Fujisawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative diseases. Her innovative work has the potential to impact the lives of many individuals suffering from various neurological conditions.
Latest Patents
Masako Miyazaki holds a patent for a heterocyclic compound that exhibits MAGL inhibitory action. This compound is expected to be useful as an agent for the prophylaxis or treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, it may aid in addressing conditions like anxiety disorders, various types of pain, epilepsy, and depression. The patent details a compound represented by a specific formula, along with its salts.
Career Highlights
Miyazaki is currently associated with Takeda Pharmaceutical Company Limited, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on improving therapeutic options for patients.
Collaborations
Some of her notable coworkers include Shuhei Ikeda and Tatsuki Koike, who contribute to her research endeavors and collaborative projects.
Conclusion
Masako Miyazaki's contributions to the field of pharmaceuticals, particularly in the area of neurodegenerative disease treatment, highlight her role as an influential inventor. Her innovative patent work and collaboration with esteemed colleagues underscore her commitment to advancing medical science.